The Government (Payer) Challenge

Horacio Falcão, Rodrigo Gouveia and Hervé Lamarque
Additional contact information
Horacio Falcão: INSEAD
Rodrigo Gouveia: Value Negotiation

Chapter 3 in Pharma, Prices and Power, 2025, pp 39-87 from Springer

Abstract: Abstract This chapter examines pricing and reimbursement (P&R) negotiations from the Payer/Government side with a negotiation eye. It describes in detail the structural and institutional challenges that increasingly make P&R negotiations harder for Governments and Payers. On the one hand, the populations are aging and suffering from more chronic illness. On the other hand, there are many more treatments (and treatment lines), higher expectations, and increasing drug prices. This leads to healthcare spending growing much faster than GDP in many countries when Governments struggle financially. The lack of funds begs the question of how to increase funding, who gets covered, by whom, and how to improve healthcare’s cost-efficiency. This chapter covers the ideas currently under discussion in the field through the eyes of negotiation and anticipating potential consequences.

Date: 2025
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:fuobcp:978-3-031-93933-4_3

Ordering information: This item can be ordered from
http://www.springer.com/9783031939334

DOI: 10.1007/978-3-031-93933-4_3

Access Statistics for this chapter

More chapters in Future of Business and Finance from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().